Biosimilars are poised to increase access to otherwise expensive therapies, but legal and regulatory hurdles abound. In an ISPOR webinar taking place on January 19th, 2022, presenters Aurelio Arias, MSc, Cate Lockhart, MS, PharmD, PhD, and Emma Foreman, BS will speak with moderator Liese Barbier about the future of biosimilars. Speakers will cover the use of real-world evidence (RWE) in biosimilar evaluations, regulatory evaluation challenges, and market opportunities.
According to ISPOR, “With another major wave of loss of exclusivities of original biological medicines expected in the next five to ten years, it is imperative that healthcare systems are well prepared to optimally leverage the competition potential of biosimilars. In this context, this webinar will first discuss the upcoming market opportunity for biosimilars, together with emerging trends across different markets.”
Click here for more information and register today!
(Source: ISPOR, January 19th, 2022)
